美洲 · 股市与财经 · BNN Bloomberg
Knight Therapeutics Announces Launch of TAVALISSE® in Brazil
Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today the launch of TAVALISSE® (fostamatinib disodium hexahydrate) in…
在 BNN Bloomberg 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.bnnbloomberg.ca)
